echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The Production Process of (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]

    The Production Process of (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]

    • Last Update: 2023-05-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The production process of (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]benzoxazepine is a complex and multi-step process that involves various chemical reactions and purification steps.
    The following is a detailed overview of the production process:


    1. Synthesis of N-phenylpropargylamine: The synthesis of N-phenylpropargylamine, a key intermediate for the production of (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]benzoxazepine, involves the reaction of phenylpropanamine with hydrogen in the presence of a platinum catalyst.
    2. Grignard reaction: The N-phenylpropargylamine is then treated with magnesium metal to form a Grignard reagent, which is then treated with a halogenating agent such as chlorine to introduce the halogen into the molecule.
    3. Acidic hydrolysis: The resulting compound is then hydrolyzed with an acid, such as hydrochloric acid, to produce the corresponding carboxylic acid.
    4. Alkylation: The carboxylic acid is then treated with a reactive alkylating agent, such as a primary or secondary alkyl halide, to introduce the alkyl group into the molecule.
    5. Hydrogenation: The resulting compound is then hydrogenated to reduce the amount of double bonds and to remove any unwanted functional groups.
    6. Deprotection: The last step in the synthesis of (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]benzoxazepine is the deprotection of the N-phenylpropargylamine group, which is accomplished by treating the compound with an acid or a base.

    The purification of (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]benzoxazepine is typically done by column chromatography using a suitable stationary phase such as silica gel or alumina.
    The use of high-performance liquid chromatography (HPLC) can also be used for purification, as well as to determine the purity of the synthesized compound.


    In conclusion, the production process of (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]benzoxazepine is a complex and multi-step process that involves various chemical reactions and purification steps.
    The key intermediate N-phenylpropargylamine is synthesized by Grignard reaction, followed by halogenation, alkylation, hydrogenation, and deprotection.
    The final product is then purified by column chromatography or HPLC.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.